Welcome to DZIF
It is the 21st century and infections are still a major challenge for medicine. What is our recourse as germs become increasingly resistant to antibiotics? What can we do to prevent the spread of a pathogen? The researchers at the German Center for Infection Research (DZIF) are tackling these and many other issues.
DZIF scientist in the Ebola crisis region
DZIF infectious disease and tropical medicine specialist Günter Fröschl, from Munich, spent two months in Liberia, to help with the largest Ebola epidemic seen to date. We spoke to him about his work in the crisis region.
Tuberculosis: Multidrug resistance is a major challenge
DZIF Professor Stefan Niemann, Forschungszentrum Borstel, explains which problems need to be solved in optimising new drugs against tuberculosis.
09 April 2015 - PRESS RELEASE
30 years after HIV was discovered to be the cause of the acquired immune deficiency syndrome (AIDS), no vaccine or cure has yet been found. An international team of scientists, in collaboration with the German Center for Infection Research (DZIF) and the University Hospital of Cologne, has now tested a new generation of antibodies in humans for the first time. They have demonstrated that these broadly neutralising antibodies significantly reduce the number of human immunodeficiency viruses (HIV) in infected patients’ blood. [ more ]
02 April 2015 - PRESS RELEASE
12 March 2015 - PRESS RELEASE
DZIF e.V. – Inhoffenstraße 7, 38124 Braunschweig, Germany
PHONE +49 531-6181 1152 EMAIL email@example.com